From LifeSiteNews

By Calvin Freiburger

Trump nominee for Secretary of Health and Human Services Robert F. Kennedy Jr. received a ringing endorsement from an acclaimed medical expert on Tuesday who said the country needs to take seriously a possible link between the COVID-19 shots and childhood cancer.

Dr. Patrick Soon-Shiong is a billionaire who pioneered the cancer drug Abraxane and has owned and led multiple medical companies. In 2018, he purchased the Los Angeles Times (which he blocked from endorsing Democrat Kamala Harris for president in 2024), and his ImmunityBio was among the companies recruited by the Trump administration to contribute to Operation Warp Speed.

On Tuesday, Soon-Shiong appeared on the 2WAY podcast, where he shared his thoughts about some of the big medical policy questions of the next four years.

“I think people misunderstand Bobby Kennedy, Robert F. Kennedy. He’s really all about the science,” he said. “I’ve sat down with him, met with him for the first time. I’ve not known him until I sat down with him, because I wanted to understand what he was thinking. And after hours of sitting down with him, I was so impressed. He knows more about the science than most doctors.”

Soon-Shiong went on to say “we’re going to have to address the rising incidence of cancer. For the first time in my career, I’ve seen an 8-year-old, 9-year-old, 10-year-old with colon cancer. The first time in my career, I’ve had a 13-year-old child in our clinic die of metastatic pancreatic cancer. We have to face this effectiveness and reality.”

The doctor ended on an optimistic note, saying that “there are effective therapies because we understand the science in such an immense way,” and adding that he is “excited about this next four years of bringing this information across and not to scare the population to say, look, we could lead the world in our innovation and using healthcare as a foreign policy around the world.”

A large body of evidence identifies significant risks to the COVID shots, which were developed and reviewed in a fraction of the time vaccines usually take under Operation Warp Speed.

The federal Vaccine Adverse Event Reporting System (VAERS) reports 38,264 deaths, 219,594 hospitalizations, 22,134 heart attacks, and 28,814 myocarditis and pericarditis cases as of December 27, among other ailments. CDC researchers have recognized a “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.

An analysis of 99 million people across eight countries published in February in the journal Vaccine “observed significantly higher risks of myocarditis following the first, second and third doses” of mRNA-based COVID shots, as well as signs of increased risk of “pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” and other “potential safety signals that require further investigation.” In April, the CDC was forced to release by court order 780,000 previously undisclosed reports of serious adverse reactions, and a study out of Japan found “statistically significant increases” in cancer deaths after third doses of mRNA-based COVID-19 injections and offered several theories for a causal link.

Earlier this month, a long-awaited Florida grand jury report on the COVID shot manufacturers found that there were “profound and serious issues” in pharmaceutical companies’ review process, including reluctance to share what evidence of adverse events they found.

All eyes are currently on Trump and his health team, which will be helmed by Kennedy at HHS. As one of the country’s most vocal critics of the COVID establishment and vaccines more generally, his nomination brought hope that the second Trump administration will take a critical reassessment of the shots that the returning president has previously embraced, although most of Kennedy’s comments since joining Trump have focused on other issues, such as conventional vaccines and harmful food additives.

Trump has given mixed signals as to the prospects of reconsidering the shots and has nominated both critics and defenders of establishment COVID measures for a number of administration roles.